Article Text
Abstract
The existing model for ethical review of medical research consists primarily of regulations designed to prevent exploitation of participants. This model may fail when reviewing other ethical obligations, particularly the responsibility to provide valuable knowledge to society. Such failure is most apparent in developing countries, in which many stakeholders lack incentives or power to uphold society’s interests. An alternative ethical model is that of partnership, which actively involves all partners during ethical review and aims to secure partners’ best interests through compromise. Unlike the existing “regulatory” model, the partnership model effectively addresses ethical obligations to provide positive benefits to society. For the partnership model to be effective, power must be shared among partners; thus, the partnership model can be harmonised with the “regulatory” model through explicit consideration of power structures. One opportunity for crafting power balance in developing countries is apparent in “implementation trials”—randomised trials motivated by and integrated into the implementation of long term public health interventions. Given the failings of the existing ethical review model, alternative models—for example, partnership—and means to balance power—for example, implementation trials—must be explored to ensure that medical research provides knowledge of value to societies in the developing world.
- GHIS, Gambia Hepatitis Intervention Study
- HBV, hepatitis B vaccine
- Clinical trials
- developing countries
- research ethics
Statistics from Altmetric.com
Footnotes
Read the full text or download the PDF:
Other content recommended for you
- Health policy and systems research: towards a better understanding and review of ethical issues
- Non-equivalent stringency of ethical review in the Baltic States: a sign of a systematic problem in Europe?
- Designing and undertaking randomised implementation trials: guide for researchers
- Streamlining review of research involving humans: Canadian models
- Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach
- Establishing ethical trials for treatment and prevention of AIDS in developing countries
- Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
- Donor-funded research: permissible, not perfect
- ‘The ethics approval took 20 months on a trial which was meant to help terminally ill cancer patients. In the end we had to send the funding back’: a survey of views on human research ethics reviews
- A comparison of justice frameworks for international research